Effect of Glucosamine Sulfate, Chondrotin Sulfate, Methylsulfonylmethane Phonophoresis on Pain, Range of Motion, Position Sense and function in Knee Osteoarthritis

Glucosamine Sulfate, Chondrotin Sulfate, Methylsulfonylmethane Phonophoresis on Knee Osteoarthritis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR20180770451482

Enrollment

Registered

2018-07-26

Start date

2018-01-18

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Phonophoresis

Topical drug application

Traditional exercise program

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility was defined as symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR) Radiographic confirmed knee OA according to the Kellgren & Lawrence scale

Exclusion criteria

Exclusion criteria: Exclusion criteria included acute septic arthritis; inflammatory arthritis; any other type of arthritis; history of knee buckling or recent knee injury; lack of physical or mental ability to perform or comply with the treatment procedure; diabetes mellitus; fibromyalgia or other chronic pain syndromes; concurrent anti-coagulant/anti-platelet drugs; arthroscopy or intra-articular injections in the previous 3 months

Design outcomes

Primary

Measure	Time frame
Pain, Range of motion and position sense	—

Secondary

Measure	Time frame
Function of the knee	—

Countries

Egypt

Contacts

Public ContactSoheir Samaan

Assistant professor

soheirsamaan@yahoo.com01224003374

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026